Posted by Mary Helen Stoltz on February 2, 2016
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. company (Symbol: VIRA) and social network for cancer patients, survivors and caretakers, announced an agreement with Missouri S&T to commercialize the device.
Read More »Posted by Mary Helen Stoltz on May 28, 2013
A Missouri University of Science and Technology researcher has developed a new screening method that uses urinalysis to diagnose breast cancer – and determine its severity – before it could be detected with a mammogram. A study to confirm this technique’s effectiveness is under way at Mercy Breast Center in Springfield, Mo.
Read More »
Missouri S&T is an equal opportunity employer
© 2025 - Curators of the University of Missouri | WordPress